Abstract 18261: Acute Normovolemic Hemodilution in Cardiac Surgery: An Updated Systematic Review and Meta Analysis of Randomized Controlled Trials
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.18261 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Muhammad Saleem und 15 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Acute normovolemic hemodilution (ANH) is an intraoperative blood conservation technique used in cardiac surgeries. However, its efficacy and safety remain controversial especially considering recent studies. We performed an updated systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating ANH in adult cardiac surgery. Research Question: Is there any benefit in using ANH as compared to using standard intraoperative care techniques in patients undergoing cardiac surgery?
Methods
We performed a comprehensive search across multiple databases, including CENTRAL, PubMed/MEDLINE, and Embase to retrieve all RCTs comparing ANH with standard intraoperative care in patients undergoing cardiac surgery. The primary outcome was the number of allogeneic red blood cell (RBC) units transfused per patient. Data analysis was performed using Review Manager. Risk ratios (RRs) and standard mean difference (SMDs), along with 95% confidence intervals (CIs) were used as effect measures for dichotomous and continuous outcomes respectively.
Results
Thirty RCTs (4,487 participants) were included. ANH significantly reduced the number of RBC units transfused (SMD –0.72, 95% CI –1.12 to –0.32; I 2 =96%) and decreased the proportion of patients receiving ≥1 transfusion (RR 0.77, 95% CI 0.67-0.88; I 2 =79%). ANH was also associated with reduced estimated blood loss (SMD –0.53, 95% CI –0.80 to –0.26; I 2 =92%) and fewer FFP units transfused (SMD –0.57, 95% CI –1.12 to –0.02; I 2 =96%). There were no significant differences in MI (RR 0.71, 95% CI 0.40-1.29), surgical revision for bleeding (RR 1.18, 95% CI 0.81-1.72), or platelet transfusion (SMD –0.02, 95% CI –0.10-0.06).
Conclusions
ANH reduces allogeneic RBC transfusion and blood loss in cardiac surgery without increasing major adverse events, although substantial heterogeneity exists across trials. Further high-quality contemporary RCTs are warranted.
Zitieren
APA
Saleem, M., PATEL, M., Sabir, A., Alabdali, M., Bahzad, S., Hasan, M. A. S., Adugna, A., Tarabeh, H., Nadeem, A., Naveed, S., Ehsan, M., Ikram, J., Haiy, A. U., Rehman, W., Nawaz, A., & Ilyas, M. A. (2026). Abstract 18261: Acute Normovolemic Hemodilution in Cardiac Surgery: An Updated Systematic Review and Meta Analysis of Randomized Controlled Trials. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.18261
Vancouver
Saleem M, PATEL M, Sabir A, Alabdali M, Bahzad S, Hasan MAS, et al. Abstract 18261: Acute Normovolemic Hemodilution in Cardiac Surgery: An Updated Systematic Review and Meta Analysis of Randomized Controlled Trials. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.18261
BibTeX
@article{Saleem2026,
author = {Saleem, Muhammad and PATEL, MRUNJ and Sabir, Alifa and Alabdali, Maath and Bahzad, Shaker and Hasan, Md Abdus Samad and Adugna, Amanuel and Tarabeh, Hilal and Nadeem, Anam and Naveed, Shawaiz and Ehsan, Muhammad and Ikram, Jibran and Haiy, Ata Ul and Rehman, Wajeeh and Nawaz, Ahmad and Ilyas, Muhammad Abdullah},
title = {Abstract 18261: Acute Normovolemic Hemodilution in Cardiac Surgery: An Updated Systematic Review and Meta Analysis of Randomized Controlled Trials},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.18261}
}
EUVIMED